Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-28 4:25 pm Purchase |
2023-07-20 | 13G | Terns Pharmaceuticals, Inc. TERN |
Deep Track Capital, LP | 3,560,000 6.280% |
3,560,000 (New Position) |
Filing History |
| 2023-07-24 4:05 pm Purchase |
2023-07-14 | 13G | Apogee Therapeutics, Inc. APGE |
Deep Track Capital, LP | 3,023,456 8.870% |
3,023,456 (New Position) |
Filing History |
| 2023-06-30 4:00 pm Purchase |
2023-06-22 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Deep Track Capital, LP | 290,322 9.990% |
290,322 (New Position) |
Filing History |
| 2023-06-15 4:02 pm Purchase |
2023-06-05 | 13G | Zura Bio Limited ZURA |
Deep Track Capital, LP | 4,205,000 9.390% |
4,205,000 (New Position) |
Filing History |
| 2023-05-19 4:23 pm Purchase |
2023-05-11 | 13G | Dynavax Technologies Corporation DVAX |
Deep Track Capital, LP | 6,556,180 5.100% |
6,556,180 (New Position) |
Filing History |
| 2023-04-14 4:35 pm Purchase |
2023-04-04 | 13G | SpringWorks Therapeutics, Inc. SWTX |
Deep Track Capital, LP | 3,254,132 5.210% |
3,254,132 (New Position) |
Filing History |
| 2023-04-14 4:34 pm Purchase |
2023-04-04 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 12,302,237 6.500% |
12,302,237 (New Position) |
Filing History |
| 2023-03-20 4:55 pm Purchase |
2023-03-10 | 13G | Pliant Therapeutics, Inc. PLRX |
Deep Track Capital, LP | 3,104,507 5.270% |
3,104,507 (New Position) |
Filing History |
| 2023-03-20 4:43 pm Purchase |
2023-03-10 | 13G | Orchard Therapeutics plc ORTX |
Deep Track Capital, LP | 19,125,150 9.990% |
19,125,150 (New Position) |
Filing History |
| 2023-02-24 4:13 pm Purchase |
2023-02-16 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 2,717,171 5.750% |
450,602 (+19.88%) |
Filing History |
| 2023-02-14 09:53 am Sale |
2022-12-31 | 13G | Keros Therapeutics, Inc. KROS |
Deep Track Capital, LP | 0 0.000% |
-1,300,000 (Position Closed) |
Filing History |
| 2023-02-14 08:59 am Purchase |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Deep Track Capital, LP | 3,312,974 7.930% |
1,493,285 (+82.06%) |
Filing History |
| 2023-02-14 08:59 am Purchase |
2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 4,582,000 7.140% |
1,146,800 (+33.38%) |
Filing History |
| 2023-02-14 08:58 am Sale |
2022-12-31 | 13G | TRICIDA INC TCDAQ |
Deep Track Capital, LP | 4,666,666 7.440% |
-1,191,163 (-20.33%) |
Filing History |
| 2023-02-14 08:57 am Purchase |
2022-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Deep Track Capital, LP | 2,727,606 6.500% |
627,606 (+29.89%) |
Filing History |
| 2023-02-14 08:56 am Purchase |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Deep Track Capital, LP | 2,837,818 9.430% |
356,818 (+14.38%) |
Filing History |
| 2023-02-14 08:53 am Sale |
2022-12-31 | 13G | Passage Bio, Inc. PASG |
Deep Track Capital, LP | 0 0.000% |
-3,216,997 (Position Closed) |
Filing History |
| 2023-02-14 08:52 am Sale |
2022-12-31 | 13G | Nuvation Bio Inc. NUVB |
Deep Track Capital, LP | 8,221,188 3.760% |
-3,250,093 (-28.33%) |
Filing History |
| 2023-02-14 08:50 am Sale |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 2,266,569 4.810% |
-169,595 (-6.96%) |
Filing History |
| 2023-02-14 08:50 am Sale |
2022-12-31 | 13G | Nkarta, Inc. NKTX |
Deep Track Capital, LP | 1,354,200 2.770% |
-611,484 (-31.11%) |
Filing History |